摘要
目的:探讨地榆升白片治疗多发性骨髓瘤化疗后白细胞减少的临床疗效的患者。方法:将48例均接受相同方案化疗,按随机数字表法分为对照组和试验组。对照组22例采用化疗药物治疗,试验组26例在对照组基础上加用地榆升白片治疗,观察两组间白细胞变化情况。结果:试验组白细胞减少程度轻于对照组(P<0.05);化疗后3周,治疗组白细胞水平较对照组稳定(P<0.05)。结论:地榆升白片治疗多发性骨髓瘤化疗后白细胞减少,可明显提升白细胞,从而预防和减少感染发生。文献引用:冯春,张萍,黄志.地榆升白片治疗多发性骨髓瘤化疗后白细胞减少临床研究[J].中医学报,2013,28(12):1794-1795.
Objective ： To investigate the clinical effect of Diyushengbai Tablet in treating leucopenia after chemotherapy for multiple mye- loma. Methods ：48 cases of patients were treated with the same chemotherapy. They were randomly divided into the control group and the experimental group. The control group of 22 cases were given chemotherapy drug and the experimental group of 26 cases were addition- ally given Diyushengbai Tablet on the basis of the control group. Observed the changes of white blood cells between the two groups. Re- sults ：The degree of leucopenia of the experimental group was lighter than the control group（ P 〈 0.05 ） ;Three weeks after chemothera- py,white blood cells levels of the treatment group was stability compared to the control group （P 〈 0.05 ）. Conclusion： Diyushengbai Tablet in treating leucopenia after chemotherapy for multiple myeloma can obviously enhance the number of white blood cells, so as to prevent and reduce the occurrence of infection.
出处
《中医学报》
CAS
2013年第12期1794-1795,共2页
Acta Chinese Medicine
基金
湖北省科技厅2011年度计划课题(编号:20113161)
